Trials / Unknown
UnknownNCT00437450
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 99 (planned)
- Sponsor
- Groupe Francophone des Myelodysplasies · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is * To evaluate the efficacy of association of Erythropoetin (Neorecormon) and ATRA in patients with low risk myelodysplastic syndromes * To evaluate the tolerance of this treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epoetin/Atra |
Timeline
- Start date
- 2004-10-01
- Completion
- 2005-09-01
- First posted
- 2007-02-21
- Last updated
- 2009-11-18
Locations
24 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00437450. Inclusion in this directory is not an endorsement.